Overall, treatment of the scleroderma patient is focused on the rapid reduction of inflammation to prevent further production of fibrosis as well as treatment of the complications of Raynaud's ...

Given that scleroderma-related lung disease is the leading cause of death in the scleroderma patient population, the identification of a blood biomarker that may be able to identify patients at ...